Editor-in-Chief
British Journal of Clinical Pharmacology
June 03, 2020
I am pleased to submit an original research article entitled
“Drugs-Induced QT Interval Prolongation among End Stage Renal
Disease Patients in Jordan”
In spite of high risk of deadly complications due to drug-induced QT
interval prolongation usage among end stage renal disease patients, no
previous studies were conducted to assess medication safety of this
drugs category among this vulnerable patients group.
In this manuscript, we show that Major drug-drug interactions and
dispensing medications with risk of developing QT interval prolongation
based on inappropriate prescribing decisions for patients with end stage
renal disease were reported to be high in outpatient clinics in Jordan.
Therefore, proper pharmaceutical care should be improved to intervene on
this events and maintain patient safety.We believe that this manuscript
is appropriate for publication by The British Journal of Clinical
Pharmacology because it links to the Journal’s aims and scope. This
manuscript has not been published and is not under consideration for
publication elsewhere. We have no conflicts of interest to disclose.
Thank you for your consideration!
Dania Abu-Naser
Al Balqa Applied University, Jordan